Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-08

Clinical Trial Update: Modification of Asthma With Soy Isoflavone [NA]

View source ↗

Summary

Northwestern University completed a clinical trial investigating whether soy isoflavone can modify asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soy Isoflavone (soy isoflavone)

Snippet

Sponsor: Northwestern University | Conditions: Asthma | NA | Status: COMPLETED